13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q2 2025. See the latest, Q2 2026 →
Reported value
$1.77T
+13% on the quarter before
Positions
5,323
350 new · 312 sold out
Top 10
36.2%
of the value
Est. gain
+$217.48B
on stocks held all quarter
Est. return
+14.9%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$5.15BAdded · 4.7% → 5.7%+10,348,184 shares
- Broadcom~$4.20BAdded · 1.1% → 1.8%+15,242,268 shares
- Circle~$2.49BNew · 0.0% → 0.1%+13,747,308 shares
- TSMC~$2.13BAdded · 0.6% → 0.8%+9,416,021 shares
- Capital One Finl Corp~$1.15BAdded · 0.1% → 0.2%+5,392,699 shares
- Mastercard~$1.14BAdded · 0.8% → 0.8%+2,035,131 shares
- Cvs Health Corp~$1.02BAdded · 0.1% → 0.2%+14,716,719 shares
- Amazon~$974.0MAdded · 4.1% → 4.3%+4,439,741 shares
- Conocophillips~$912.4MAdded · 0.0% → 0.1%+10,167,065 shares
- Brown & Brown Inc~$876.5MAdded · 0.0% → 0.1%+7,905,288 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$4.38BCut · 4.7% → 3.5%−21,341,586 shares
- Arista Networks~$2.53BCut · 0.2% → 0.1%−24,688,147 shares
- Berkshire Hathaway Inc Del~$2.41BCut · 0.5% → 0.2%−4,953,804 shares
- Unitedhealth Group Inc~$2.31BCut · 0.8% → 0.3%−7,414,111 shares
- Regeneron Pharmaceuticals~$2.24BCut · 0.3% → 0.1%−4,271,533 shares
- Eli Lilly~$2.21BCut · 1.5% → 1.1%−2,838,895 shares
- Boston Scientific Corp~$2.18BCut · 0.8% → 0.7%−20,286,637 shares
- Oracle~$1.56BCut · 0.3% → 0.3%−7,143,518 shares
- Jpmorgan Chase & Co.~$1.44BCut · 0.7% → 0.7%−4,962,193 shares
- Salesforce~$1.33BCut · 0.3% → 0.2%−4,886,490 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −0.4% · price +45.8% | 8.9% | $157.67B | +$49.51B | ||||||||
| MicrosoftCOM · shares +5.3% · price +32.5% | 5.7% | $101.94B | +$23.74B | ||||||||
| MetaCL A · shares +0.5% · price +28.1% | 5.7% | $100.31B | +$21.86B | ||||||||
| AmazonCOM · shares +1.3% · price +15.3% | 4.3% | $75.49B | +$9.89B | ||||||||
| AppleCOM · shares −6.5% · price −7.6% | 3.5% | $62.94B | −$5.20B | ||||||||
| AlphabetCAP STK CL A · shares −2.2% · price +14.0% | 2.2% | $38.13B | +$4.67B | ||||||||
| BroadcomCOM · shares +15% · price +64.6% | 1.8% | $32.28B | +$11.02B | ||||||||
| NetflixCOM · shares −1.0% · price +43.6% | 1.7% | $29.58B | +$8.98B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.01% · price −8.7% | 1.4% | $24.23B | −$2.32B | ||||||||
| Eli LillyCOM · shares −10.0% · price −5.6% | 1.1% | $19.98B | −$1.19B | ||||||||
| Visa Inc.COM CL A · shares −2.3% · price +1.3% | 1.1% | $19.83B | +$256.4M | ||||||||
| AlphabetCAP STK CL C · shares −3.1% · price +13.5% | 1.0% | $18.06B | +$2.15B | ||||||||
| Wells Fargo Co NewCOM · shares −2.0% · price +11.6% | 0.91% | $16.13B | +$1.68B | ||||||||
| Ge AerospaceCOM NEW · shares −5.6% · price +28.6% | 0.88% | $15.55B | +$3.46B | ||||||||
| Exxon Mobil CorpCOM · shares −5.9% · price −9.4% | 0.81% | $14.38B | −$1.48B | ||||||||
| MastercardCL A · shares +8.9% · price +2.5% | 0.79% | $13.96B | +$315.1M | ||||||||
| TSMCSPONSORED ADS · shares +18% · price +36.4% | 0.78% | $13.91B | +$3.14B | ||||||||
| GE VernovaCOM · shares +4.1% · price +73.3% | 0.74% | $13.11B | +$5.33B | ||||||||
| Jpmorgan Chase & Co.COM · shares −11% · price +18.2% | 0.69% | $12.19B | +$1.88B | ||||||||
| Boston Scientific CorpCOM · shares −16% · price +6.5% | 0.66% | $11.63B | +$707.3M | ||||||||
| AmphenolCL A · shares +3.5% · price +50.6% | 0.61% | $10.73B | +$3.48B | ||||||||
| Bank America CorpCOM · shares +2.9% · price +13.4% | 0.56% | $9.91B | +$1.14B | ||||||||
| TeslaCOM · shares −1.1% · price +22.6% | 0.54% | $9.50B | +$1.75B | ||||||||
| Costco Whsl Corp NewCOM · shares −1.1% · price +4.7% | 0.53% | $9.32B | +$415.7M | ||||||||
| Marvell Technology IncCOM · shares −7.3% · price +25.7% | 0.50% | $8.89B | +$1.82B | ||||||||
| Total · 5,323 positions | 100% | $1.77T | +$217.48B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 4,798 stocks held throughout, up $217.48B (+14.9%).
- Nvidia+$49.51B+46%
- Microsoft+$23.74B+33%
- Meta+$21.86B+28%
- Broadcom+$11.02B+65%
- Amazon+$9.89B+15%
- Eli Lilly−$1.19B−6%
- Exxon Mobil Corp−$1.48B−9%
- Berkshire Hathaway Inc Del−$2.32B−9%
- Unitedhealth Group Inc−$3.56B−40%
- Apple−$5.20B−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 23 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |